Krystal Biotech Announced Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates

Krystal Biotech
Today, February 26, 2024, Krystal Biotech (KRYS) firm announces its full year financial results and business updates.  Read this press release to learn about the company.

  • New England Journal of Medicine publication of the use of B-VEC eyedrop formulation.
  • Reached alignment with FDA to enable approval of B-VEC eyedrop formulation . . .
    This content is for paid subscribers.
    Please click here to subscribe or here to log in.